Skip to main content

Tavotek Biotherapeutics

Gwynedd, United States

Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.

$35.0M raised
Nov 2021
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tavotek Biotherapeutics

How much funding has Tavotek Biotherapeutics raised?
Tavotek Biotherapeutics has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Who are Tavotek Biotherapeutics's investors?
Tavotek Biotherapeutics's investors include Apricot Capital, BioVenture, GF Xinde Investment Management, Oriza Holdings, New Alliance Capital.
Where is Tavotek Biotherapeutics headquartered?
Tavotek Biotherapeutics is headquartered in Gwynedd, United States.
What does Tavotek Biotherapeutics do?
Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.
What stage is Tavotek Biotherapeutics at?
Tavotek Biotherapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Tavotek Biotherapeutics — Funding & Investors." VCBacked, November 18, 2021, https://www.vcbacked.co/company/tavotek-biotherapeutics. Accessed July 4, 2026.
APA
VCBacked. (2021). Tavotek Biotherapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/tavotek-biotherapeutics
Wikipedia (cite web)
{{cite web |title=Tavotek Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tavotek-biotherapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .